Skip to main content
Journal cover image

Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease

Publication ,  Conference
Kurtzberg, J; Prockop, SE; Prasad, VK; Chaudhury, S; Teira, P; Nemecek, E; Horn, B; Burke, E; Hayes, J; Skerrett, D
Published in: Biology of Blood and Marrow Transplantation
February 2015

Duke Scholars

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2015

Volume

21

Issue

2

Start / End Page

S338 / S339

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kurtzberg, J., Prockop, S. E., Prasad, V. K., Chaudhury, S., Teira, P., Nemecek, E., … Skerrett, D. (2015). Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease. In Biology of Blood and Marrow Transplantation (Vol. 21, pp. S338–S339). Elsevier BV. https://doi.org/10.1016/j.bbmt.2014.11.539
Kurtzberg, Joanne, Susan E. Prockop, Vinod K. Prasad, Sonali Chaudhury, Pierre Teira, Eneida Nemecek, Biljana Horn, Elizabeth Burke, Jack Hayes, and Donna Skerrett. “Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease.” In Biology of Blood and Marrow Transplantation, 21:S338–39. Elsevier BV, 2015. https://doi.org/10.1016/j.bbmt.2014.11.539.
Kurtzberg J, Prockop SE, Prasad VK, Chaudhury S, Teira P, Nemecek E, et al. Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease. In: Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S338–9.
Kurtzberg, Joanne, et al. “Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease.” Biology of Blood and Marrow Transplantation, vol. 21, no. 2, Elsevier BV, 2015, pp. S338–39. Crossref, doi:10.1016/j.bbmt.2014.11.539.
Kurtzberg J, Prockop SE, Prasad VK, Chaudhury S, Teira P, Nemecek E, Horn B, Burke E, Hayes J, Skerrett D. Treatment with Human Mesenchymal Stem Cells (Remestemcel-L) Is Effective in Pediatric Patients with Refractory Acute Graft Versus Host Disease. Biology of Blood and Marrow Transplantation. Elsevier BV; 2015. p. S338–S339.
Journal cover image

Published In

Biology of Blood and Marrow Transplantation

DOI

ISSN

1083-8791

Publication Date

February 2015

Volume

21

Issue

2

Start / End Page

S338 / S339

Publisher

Elsevier BV

Related Subject Headings

  • Immunology
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences